Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Impact of an Artificial Intelligence-Based Model for Intracranial Aneurysm Detection in CT Angiography on Patients' Diagnosis and Outcomes: The IDEAL Study - A Web-Based Multicenter, Double-Blinded Randomized Controlled Trial

NCT06118840 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.

NCT NCT06118840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06118840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Impact of an Artificial Intelligence-Based Model for Intracranial Aneurysm Detection in CT Angiography on Patients' Diagnosis and Outcomes: The IDEAL Study - A Web-Based Multicenter, Double-Blinded Randomized Controlled Trial
Lead sponsor
Jinling Hospital, China
Phase
Not applicable
Overall status
Recruiting
Start date
May 20, 2024
Completion date
December 31, 2026
Enrollment
6,450 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

ct angiography, deep learning, double bind interaction, intracranial aneurysm